Top Glove sees demand doubling when vaccines ready by year-end


Its chairman Tan Sri Lim Wee Chai said that over the long term, the glove business remained good and healthy, with the company's share price depending on the earnings and performance.

KUALA LUMPUR: While pharmaceutical companies are gaining momentum on positive COVID-19 vaccination news, Top Glove Corporation Bhd expects demand for examination gloves to double when the vaccines are ready by year-end.

Its chairman Tan Sri Lim Wee Chai said that over the long term, the glove business remained good and healthy, with the company's share price depending on the earnings and performance.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Top Glove , Demand , Covid-19 update , Lim Wee Chai

   

Next In Business News

China, other countries to spur trade
Rakuten logs US$213bil quarterly loss as mobile losses negate fintech growth
Sony posts 7% fall in annual profit, narrowly misses PS5 target
UK regular pay grows by stronger-than-expected 6%
Australia's Qantas to suspend Shanghai flights on low demand
Delivery Hero in US$1.25bil deal with Uber for foodpanda Taiwan sale, investment
FBM KLCI rises slightly at midday, YTL stocks rally
ABM, AIBIM urges public to beware of fake NSRC officers
Mi Tech to reap China demand for test handlers
Ringgit retreats to open easier ahead of US inflation readings

Others Also Read